Glen Santangelo Analyst PerformanceManaging Director at BarclaysGlen Santangelo is a stock analyst at Barclays focused in the medical sector, covering 38 publicly traded companies. Over the past year, Glen Santangelo has issued 105 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Glen Santangelo's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Glen Santangelo's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings119 Last 11 YearsBuy Recommendations67.52% 79 Buy RatingsCompanies Covered38 Unique Companies Ratings Distribution117RatingsDistribution of strong buy, buy, hold, and sell ratings by Glen Santangelo.RatingPercentageCount Strong Buy5.1%6 ratings Buy62.4%73 ratings Hold24.8%29 ratings Sell7.7%9 ratingsOut of 117 total stock ratings issued by Glen Santangelo at Barclays, the majority (62.4%) have been Buy recommendations, followed by 24.8% Hold, 7.7% Sell, and 5.1% Strong Buy.Best & Worst CallsBest Call000.0%XERSJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%WAYFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ57.9% of companies on NASDAQ22 companiesNYSE42.1% of companies on NYSE16 companiesGlen Santangelo, an analyst at Barclays, currently covers 38 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical34 companies89.5%Manufacturing1 company2.6%Computer and Technology1 company2.6%Services1 company2.6%Consumer Discretionary1 company2.6%Glen Santangelo of Barclays specializes in stock coverage within the Medical sector, with additional focus on Manufacturing and Computer and Technology companies.Coverage IndustriesIndustryPercentageMEDICAL SERVICES8 companies21.1%MED - DRUGS5 companies13.2%MED/DENTAL - SUPP5 companies13.2%MED - BIOMED/GENE5 companies13.2%MEDICAL INFO SYS4 companies10.5%MED - GENERIC DRG3 companies7.9%MED PRODUCTS1 company2.6%SURGICAL, MEDICAL, AND DENTAL INSTRUMENTS AND SUPPLIES1 company2.6%INTERNET SOFTWARE1 company2.6%SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING1 company2.6%BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED1 company2.6%MED INSTRUMENTS1 company2.6%LEISURE&REC PRD1 company2.6%MED - OUTP/HM CRE1 company2.6% Glen Santangelo's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsINDVIndivior6/18/2026Initiated Coverage$37.93$46.00Overweight$0.0000.00% ROIINDVIndivior6/18/2026Initiated Coverage$38.28$46.00Overweight$0.0000.00% ROIHIMSHims & Hers Health6/17/2026Boost Price Target$31.97$39.00Overweight$0.0000.00% ROINVSTEnvista6/11/2026Lower Price Target$24.05$32.00Overweight$0.0000.00% ROICORCencora6/10/2026Lower Price Target$279.15$350.00Overweight$0.0000.00% ROIMCKMcKesson6/10/2026Lower Price Target$791.49$925.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA6/4/2026Lower Price Target$9.75$9.00Underweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals6/3/2026Lower Price Target$18.45$20.00Equal Weight$0.0000.00% ROIMDLNMedline6/1/2026Lower Price Target$36.56$45.00Overweight$0.0000.00% ROIWAYWaystar5/20/2026Lower Price Target$19.60$25.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. AMRXAmneal Pharmaceuticals5/20/2026Boost Price Target$11.81$16.00Overweight$0.0000.00% ROIWAYWaystar5/20/2026Lower Price Target$19.21$25.00Overweight$0.0000.00% ROIVTRSViatris5/19/2026Boost Price Target$16.50$22.00Overweight$0.0000.00% ROIPGNYProgyny5/15/2026Boost Price Target$23.25$27.00Overweight$0.0000.00% ROIPHRPhreesia5/14/2026Reiterated Rating$8.77$10.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Reiterated Rating$17.94$20.00Equal Weight$0.0000.00% ROIDOCSDoximity5/14/2026Downgrade$18.93$20.00Equal Weight$0.0000.00% ROIPHRPhreesia5/14/2026Downgrade$8.78$10.00Equal Weight$0.0000.00% ROITEVATeva Pharmaceutical Industries5/6/2026Boost Price Target$35.85$40.00Overweight$0.0000.00% ROICTEVClaritev4/24/2026Initiated Coverage$20.34$28.00Overweight$0.0000.00% ROICTEVClaritev4/24/2026Initiated Coverage$23.84$28.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals4/8/2026Lower Price Target$20.49$23.00Equal Weight$0.0000.00% ROIPHATPhathom Pharmaceuticals3/27/2026Upgrade$10.79$18.00Overweight$0.0000.00% ROITDOCTeladoc Health3/26/2026Lower Price Target$5.57$7.00Equal Weight$0.0000.00% ROIPCRXPacira BioSciences3/26/2026Lower Price Target$23.49$25.00Equal Weight$0.0000.00% ROIVTRSViatris3/24/2026Boost Price Target$13.32$17.00Overweight$0.0000.00% ROIALVOAlvotech3/24/2026Lower Price Target$3.07$4.00Underweight$0.0000.00% ROIPGNYProgyny3/20/2026Lower Price Target$17.93$23.00Overweight$0.0000.00% ROIALGNAlign Technology3/17/2026Upgrade$169.45$200.00Overweight$0.0000.00% ROIHIMSHims & Hers Health3/11/2026Boost Price Target$26.25$29.00Overweight$0.0000.00% ROITALKTalkspace3/9/2026Lower Price Target$5.12$5.25Equal Weight$0.0000.00% ROIALGNAlign Technology2/25/2026Boost Price Target$187.52$200.00Equal Weight$0.0000.00% ROIBHCBausch Health Cos2/25/2026Lower Price Target$6.16$7.00Equal Weight$0.0000.00% ROIHIMSHims & Hers Health2/24/2026Lower Price Target$15.93$25.00Overweight$0.0000.00% ROICAHCardinal Health2/24/2026Boost Price Target$224.83$258.00Overweight$0.0000.00% ROIOGNOrganon & Co.2/24/2026Boost Price Target$7.91$8.00Underweight$0.0000.00% ROIHQYHealthEquity2/19/2026Set Price Target$78.86$108.00$0.0000.00% ROIMCKMcKesson2/18/2026Boost Price Target$946.46$1,050.00Overweight$0.0000.00% ROIHQYHealthEquity2/18/2026Lower Price Target$74.36$110.00Overweight$0.0000.00% ROICORCencora2/13/2026Boost Price Target$351.91$425.00Overweight$0.0000.00% ROILouis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock freeDOCSDoximity2/11/2026Lower Price Target$27.28$38.00Overweight$0.0000.00% ROINVSTEnvista2/11/2026Boost Price Target$29.78$34.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories2/5/2026Lower Price Target$642.94$800.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries1/30/2026Boost Price Target$33.70$38.00Overweight$0.0000.00% ROIGDRXGoodRx1/22/2026Downgrade$2.58Hold$0.0000.00% ROIGDRXGoodRx1/22/2026Reiterated Rating$2.58$2.75Hold$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$50.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical1/9/2026Lower Price Target$47.12$56.00Overweight$0.0000.00% ROITEVATeva Pharmaceutical Industries1/6/2026Boost Price Target$32.12$40.00Buy$0.0000.00% ROIPHRPhreesia12/16/2025Lower Price Target$16.70$24.00Overweight$0.0000.00% ROIASAmer Sports12/9/2025Initiated Coverage$37.23$49.00Overweight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals12/9/2025Initiated Coverage$26.01$30.00Equal Weight$0.0000.00% ROIELANElanco Animal Health12/9/2025Initiated Coverage$21.69$30.00Overweight$0.0000.00% ROIOGNOrganon & Co.12/9/2025Initiated Coverage$7.30$7.50Underweight$0.0000.00% ROIPCRXPacira BioSciences12/9/2025Initiated Coverage$24.42$27.00Equal Weight$0.0000.00% ROITDOCTeladoc Health12/9/2025Initiated Coverage$7.56$8.50Equal Weight$0.0000.00% ROITEVATeva Pharmaceutical Industries12/9/2025Initiated Coverage$28.32$35.00Overweight$0.0000.00% ROIANIPANI Pharmaceuticals12/9/2025Initiated Coverage$82.80$100.00Overweight$0.0000.00% ROIASAmer Sports12/9/2025Initiated Coverage$38.65$49.00Overweight$0.0000.00% ROIZTSZoetis12/8/2025Initiated Coverage$118.09$136.00Equal Weight$0.0000.00% ROIXERSXeris Biopharma12/8/2025Initiated Coverage$6.99$9.00Overweight$0.0000.00% ROIVTRSViatris12/8/2025Initiated Coverage$11.09$15.00Overweight$0.0000.00% ROITARSTarsus Pharmaceuticals12/8/2025Initiated Coverage$82.23$100.00Overweight$0.0000.00% ROIIDXXIDEXX Laboratories12/8/2025Initiated Coverage$706.65$850.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical12/8/2025Initiated Coverage$47.91$58.00Overweight$0.0000.00% ROIBHCBausch Health Cos12/8/2025Initiated Coverage$6.84$8.00Equal Weight$0.0000.00% ROIAMRXAmneal Pharmaceuticals12/8/2025Initiated Coverage$11.87$15.00Overweight$0.0000.00% ROIALVOAlvotech12/8/2025Initiated Coverage$5.45$5.00Underweight$0.0000.00% ROITALKTalkspace12/8/2025Initiated Coverage$3.13$3.50Equal Weight$0.0000.00% ROIPHRPhreesia12/8/2025Initiated Coverage$20.28$26.00Overweight$0.0000.00% ROIMCKMcKesson12/8/2025Initiated Coverage$797.42$960.00Overweight$0.0000.00% ROIHSICHenry Schein12/8/2025Initiated Coverage$72.86$86.00Overweight$0.0000.00% ROIGDRXGoodRx12/8/2025Initiated Coverage$2.72$3.00Underweight$0.0000.00% ROINVSTEnvista12/8/2025Initiated Coverage$20.00$24.00Overweight$0.0000.00% ROIDOCSDoximity12/8/2025Initiated Coverage$45.77$63.00Overweight$0.0000.00% ROICORCencora12/8/2025Initiated Coverage$337.67$400.00Overweight$0.0000.00% ROICAHCardinal Health12/8/2025Initiated Coverage$198.48$243.00Overweight$0.0000.00% ROIALGNAlign Technology12/8/2025Initiated Coverage$157.68$170.00Equal Weight$0.0000.00% ROIXRAYDENTSPLY SIRONA12/8/2025Initiated Coverage$11.10$12.00Underweight$0.0000.00% ROIHIMSHims & Hers Health12/8/2025Initiated Coverage$39.05$48.00Overweight$0.0000.00% ROIALGNAlign Technology12/8/2025Initiated Coverage$159.00$170.00Equal Weight$0.0000.00% ROIAMPHAmphastar Pharmaceuticals12/8/2025Upgrade$25.65Hold$0.0000.00% ROIAMRXAmneal Pharmaceuticals12/8/2025Initiated Coverage$11.97$15.00Overweight$0.0000.00% ROIBHCBausch Health Cos12/8/2025Initiated Coverage$6.80$8.00Equal Weight$0.0000.00% ROICAHCardinal Health12/8/2025Initiated Coverage$198.01$243.00Overweight$0.0000.00% ROICOLLCollegium Pharmaceutical12/8/2025Initiated Coverage$47.03$58.00Overweight$0.0000.00% ROIDOCSDoximity12/8/2025Initiated Coverage$45.17$63.00Overweight$0.0000.00% ROIELANElanco Animal Health12/8/2025Upgrade$20.45Strong-Buy$0.0000.00% ROIHIMSHims & Hers Health12/8/2025Initiated Coverage$39.67$48.00Overweight$0.0000.00% ROIHSICHenry Schein12/8/2025Initiated Coverage$74.44$86.00Overweight$0.0000.00% ROIThe REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.IDXXIDEXX Laboratories12/8/2025Initiated Coverage$699.06$850.00Overweight$0.0000.00% ROINVSTEnvista12/8/2025Initiated Coverage$20.61$24.00Overweight$0.0000.00% ROIOGNOrganon & Co.12/8/2025Upgrade$6.93Strong Sell$0.0000.00% ROIPCRXPacira BioSciences12/8/2025Upgrade$24.77Hold$0.0000.00% ROIPHRPhreesia12/8/2025Initiated Coverage$15.46$26.00Overweight$0.0000.00% ROITDOCTeladoc Health12/8/2025Upgrade$7.73Hold$0.0000.00% ROITEVATeva Pharmaceutical Industries12/8/2025Upgrade$28.56Strong-Buy$0.0000.00% ROIVTRSViatris12/8/2025Initiated Coverage$11.19$15.00Overweight$0.0000.00% ROIXERSXeris Biopharma12/8/2025Initiated Coverage$7.01$9.00Overweight$0.0000.00% ROIXRAYDENTSPLY SIRONA12/8/2025Initiated Coverage$11.11$12.00Underweight$0.0000.00% ROICORCencora12/8/2025Upgrade$340.63Strong-Buy$0.0000.00% ROIHQYHealthEquity12/8/2025Upgrade$95.73Strong-Buy$0.0000.00% ROIMCKMcKesson12/8/2025Upgrade$813.74Strong-Buy$0.0000.00% ROITARSTarsus Pharmaceuticals12/8/2025Upgrade$81.32Strong-Buy$0.0000.00% ROIHQYHealthEquity9/3/2025Boost Price Target$93.90$134.00Buy$0.0000.00% ROITDOCTeladoc Health4/21/2025Lower Price Target$6.45$8.00Hold$0.0000.00% ROIANIPANI Pharmaceuticals3/14/2025Initiated Coverage$61.46$80.00Buy$00.0000.00% ROIVTRSViatris3/7/2025Lower Price Target$9.58$13.00Buy$00.0000.00% ROIWAYWaystar2/11/2025Initiated Coverage$41.45$51.00Buy$00.0000.00% ROIXERSXeris Biopharma1/29/2025Reiterated Rating$3.66$6.00Buy$0.0000.00% ROIXRAYDENTSPLY SIRONA1/23/2025Downgrade$19.36$20.00Hold$00.0000.00% ROINVSTEnvista1/23/2025Boost Price Target$21.18$22.00Hold$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
